ArticleBMC infectious diseases2026
Prevalence and risk factors associated with asymptomatic bacteriuria in diabetic postmenopausal women in Tripoli, Libya.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAsymptomatic bacteriuria (ASB) is more widespread in postmenopausal women, especially among diabetic women. Nevertheless, a comprehensive definition of independent predictors of ASB in the general postmenopausal population and in the high-risk diabetic subgroup remains critical for management strategies.
methodsThe study was a cross-sectional examination of the prevalence of ASB and risk factors among 400 postmenopausal women (251 with diabetes, 149 without diabetes). Quantitative culture on midstream urine samples was done according to the standard microbiological practices. Structured questionnaires and medical records were used to get clinical and demographic data. Multivariate logistic regression was employed to determine independent factors associated with ASB.
resultsThe general prevalence of ASB was 22.0% (n = 88), with a significantly higher rate in diabetic women compared to the control group (27.9% vs. 12.1%; p < 0.001). In the overall population, diabetes status (OR = 8.59; 95% CI: 1.99–37.0), HbA1c (OR = 2.52), and prior UTI history (OR = 3.98) were strong independent predictors. Within the diabetic subgroup, HbA1c (OR = 2.61; p < 0.001), history of UTIs (OR = 3.68), and age (OR = 1.13) remained the most significant predictors. Notably, the duration of diabetes was not a significant factor in this cohort.
conclusionASB is highly prevalent in diabetic postmenopausal women and strongly linked to poor glycaemic control, increased age, prior UTI, and exposure to antibiotics. These results highlight the importance of more focused prevention strategies and glycaemic control instead of general screening of ASB among this high-risk group. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.